PlainRecalls
FDA Devices Moderate Class II Ongoing

HardyCHROM CRE, selective and differential culture medium for antimicrobial susceptibility testing, Product Catalog No. G323

Reported: July 9, 2025 Initiated: May 6, 2025 #Z-2041-2025

Product Description

HardyCHROM CRE, selective and differential culture medium for antimicrobial susceptibility testing, Product Catalog No. G323

Reason for Recall

Identified lots failed incoming quality control testing. Lots exhibited breakthrough growth of Klebsiella pneumoniae.

Details

Recalling Firm
Hardy Diagnostics
Units Affected
4300 ea
Distribution
US domestic distribution to the following states: AZ, CA, CO, FL, GA, IL, MD, ME, MI, MN, MO, NC, NE, NV, NY, PA, PR, TX, UT, VA, WI and WV.
Location
Santa Maria, CA

Frequently Asked Questions

What product was recalled?
HardyCHROM CRE, selective and differential culture medium for antimicrobial susceptibility testing, Product Catalog No. G323. Recalled by Hardy Diagnostics. Units affected: 4300 ea.
Why was this product recalled?
Identified lots failed incoming quality control testing. Lots exhibited breakthrough growth of Klebsiella pneumoniae.
Which agency issued this recall?
This recall was issued by the FDA Devices on July 9, 2025. Severity: Moderate. Recall number: Z-2041-2025.